Former X CEO Linda Yaccarino is celebrating her new company with a "milestone day" Monday. Here's the latest for the former X ...

Aon has invested in eMed Population Health, a provider of GLP-1 programs, to expand employer-sponsored access to GLP-1 ...

Morgan Stanley raised the firm’s price target on Aon plc (AON) to $385 from $365 and keeps an Equal Weight rating on the shares. The firm is updating its price targets on Property & Casualty Insurance ...

DTSS' Acoustic innovation Addresses the Healthcare Application Market Projected to Exceed $100 Billion in China and Approach $90 Billion Globally by 2030 ...

Strategic investment is accelerating the transformation of employer-focused obesity solutions to boost adherence, retention and deliver breakthrough health outcomes with cost savings DUBLIN ...

Aon plc (AON) announced a strategic investment in eMed Population Health, an emerging leader in the delivery of GLP-1 programs. The partnership ...

Linda Yaccarino, the former CEO of Elon Musk 's social media platform X, has been appointed as the new CEO of eMed Population ...

Yaccarino, an advertising industry veteran, exited Elon Musk's X after two turbulent years during which she tried to revive ...

Linda Yaccarino, the former X CEO who left the social media company in the wake of yet another Elon Musk controversy, has been named the top executive at health company eMed.

Linda Yaccarino’s next role after departing X as CEO will be another chief executive role at eMed Population Health, an AI startup building a tech platform for patients using GLP-1s.

Linda Yaccarino, less than a month after stepping down as CEO of Elon Musk’s X, has found her next gig. Yaccarino has been named CEO of Miami-based eMed Population Health, which calls itself ...